British journal of cancer · 2026
Identification of microRNAs as biomarkers for triage of cervical intraepithelial neoplasia in cervical scrape samples from high-risk HPV-positive women.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mejia Guarnizo Lidy Vannessa, Trujillo Gama Clara Esperanza, López Kleine Liliana, Orozco Castaño Carlos Alberto, Prada Padilla Sebastián, Rodríguez García Josefa Antonia, Bravo Hernandez María Mercedes
Аннотация
BACKGROUND: Cervical cancer (CC) is the fourth leading cause of cancer death in women worldwide. High-risk human papillomavirus (HR-HPV) testing is highly sensitive but lacks specificity for identifying women at risk of progression. Reliable biomarkers are urgently needed to identify HR-HPV-positive women most likely to develop cervical cancer. Aberrant microRNA (miRNA) expression contributes to HPV-driven carcinogenesis and represents a promising diagnostic tool.
METHODS: Cervical scrape samples from HR-HPV-positive women were histologically classified as low-grade (≤CIN1) or high-grade (CIN2/3). Total RNA was extracted and small RNA sequencing performed to identify differentially expressed miRNAs. Bioinformatic analyses included clustering, ROC curves, logistic regression, and functional enrichment. Selected candidates were validated byRT-qPCR in independent samples.
RESULTS: Nineteen dysregulated miRNAs distinguished low- from high-grade lesions, six linked to viral and cancer pathways. Three (hsa-miR-501-3p, hsa-miR-1271-5p, hsa-miR-9-5p) were validated by RT-qPCR and showed strong discriminatory capacity. hsa-miR-501-3p reached high diagnostic accuracy (AUC = 0.88), which improved to 0.94 when combined with the others. The validated signature achieved high sensitivity and specificity for detecting high-grade lesions.
CONCLUSION: This pioneering study in Colombia using cervical scrapes demonstrates that miRNAs are potential biomarkers for high-grade cervical lesions and that this clinically relevant, minimally invasive sample routinely collected in screening supports their use.
METHODS: Cervical scrape samples from HR-HPV-positive women were histologically classified as low-grade (≤CIN1) or high-grade (CIN2/3). Total RNA was extracted and small RNA sequencing performed to identify differentially expressed miRNAs. Bioinformatic analyses included clustering, ROC curves, logistic regression, and functional enrichment. Selected candidates were validated byRT-qPCR in independent samples.
RESULTS: Nineteen dysregulated miRNAs distinguished low- from high-grade lesions, six linked to viral and cancer pathways. Three (hsa-miR-501-3p, hsa-miR-1271-5p, hsa-miR-9-5p) were validated by RT-qPCR and showed strong discriminatory capacity. hsa-miR-501-3p reached high diagnostic accuracy (AUC = 0.88), which improved to 0.94 when combined with the others. The validated signature achieved high sensitivity and specificity for detecting high-grade lesions.
CONCLUSION: This pioneering study in Colombia using cervical scrapes demonstrates that miRNAs are potential biomarkers for high-grade cervical lesions and that this clinically relevant, minimally invasive sample routinely collected in screening supports their use.